Other
prediction model
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Other(5)
Detailed Status
unknown5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
N/A
Trials by Status
unknown5100%
Recent Activity
0 active trials
Showing 5 of 5
unknown
Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer
NCT06192030
unknown
Assessment of Ovarian Cysts Using Machine Learning
NCT05342298
unknown
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
NCT05194605
unknown
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
NCT05181332
unknown
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma
NCT05171413
Clinical Trials (5)
Showing 5 of 5 trials
NCT06192030
Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer
NCT05342298
Assessment of Ovarian Cysts Using Machine Learning
NCT05194605
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
NCT05181332
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
NCT05171413
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5